Malaria Vaccine

A new "high efficacy" malaria vaccine co-developed by the Serum Institute of India (SII) and the University of Oxford was officially rolled out on Monday when Cote d'Ivoire in West Africa became the first country to begin administering R21/Matrix-M.

Vaccines manufacturer Serum Institute of India (SII) on Monday said it has started exports of 'R21/Matrix-M' malaria vaccine to Africa as part of the global fight against the disease.

The R21/Matrix-M malaria vaccine developed by the University of Oxford and the Serum Institute of India has been recommended for use by the World Health Organisation (WHO) after meeting required safety, quality and effectiveness standards.

The World Health Organization said Monday that its experts had recommended a second malaria vaccine for children, R21/Matrix-M, developed by Britain's Oxford University.

A University of Oxford developed and Serum Institute of India (SII) manufactured and scaled up "high efficacy" malaria vaccine has been licensed for use in Ghana by Africa's Food and Drugs Authority, the university announced here on Thursday.

India's drug regulator has allowed the export of the first produced-in-India vaccine against malaria, developed by scientists at the University of Oxford and manufactured by Serum Institute to the UK.

The AlphaFold software by Google’s DeepMind has predicted nearly all protein structures known to science. These have been stored in the AlphaFold DB for researchers to easily access.

After decades of work, the World Health Organization endorsed the first-ever malaria vaccine last year - a historic milestone that promised to drive back a disease that kills a child every minute.

The World Health Organization on Wednesday endorsed the RTS,S/AS01 malaria vaccine for children, the first against the mosquito-borne disease that kills more than 400,000 a year.

Despite many vaccines tested over the years, this is the first to meet the required WHO’s required efficacy target.

An under-trial malaria vaccine was hailed as delivering "unprecedented efficacy levels" to achieve the WHO specified goal of 75 per cent efficacy and is now set to enter the next stage of trials, in collaboration with the Serum Institute of India.

Britain's GSK will shift production of the world's first effective malaria vaccine to Indian COVID-19 vaccine developer Bharat Biotech, as part of global efforts to battle the deadly fever, the drugmakers said on Wednesday.

Malaria is associated with high grade fever and is transmitted by the bite of an Anopheles mosquito.

Pakistan's government has launched a huge foreign-funded vaccination drive against typhoid that began on Nov 15.

World Malaria Day: In clinical trials, the vaccine was found to prevent about four in ten malaria cases, including three in ten cases of life-threatening severe malaria: reports.

A new "high efficacy" malaria vaccine co-developed by the Serum Institute of India (SII) and the University of Oxford was officially rolled out on Monday when Cote d'Ivoire in West Africa became the first country to begin administering R21/Matrix-M.

Vaccines manufacturer Serum Institute of India (SII) on Monday said it has started exports of 'R21/Matrix-M' malaria vaccine to Africa as part of the global fight against the disease.

The R21/Matrix-M malaria vaccine developed by the University of Oxford and the Serum Institute of India has been recommended for use by the World Health Organisation (WHO) after meeting required safety, quality and effectiveness standards.

The World Health Organization said Monday that its experts had recommended a second malaria vaccine for children, R21/Matrix-M, developed by Britain's Oxford University.

A University of Oxford developed and Serum Institute of India (SII) manufactured and scaled up "high efficacy" malaria vaccine has been licensed for use in Ghana by Africa's Food and Drugs Authority, the university announced here on Thursday.

India's drug regulator has allowed the export of the first produced-in-India vaccine against malaria, developed by scientists at the University of Oxford and manufactured by Serum Institute to the UK.

The AlphaFold software by Google’s DeepMind has predicted nearly all protein structures known to science. These have been stored in the AlphaFold DB for researchers to easily access.

After decades of work, the World Health Organization endorsed the first-ever malaria vaccine last year - a historic milestone that promised to drive back a disease that kills a child every minute.

The World Health Organization on Wednesday endorsed the RTS,S/AS01 malaria vaccine for children, the first against the mosquito-borne disease that kills more than 400,000 a year.

Despite many vaccines tested over the years, this is the first to meet the required WHO’s required efficacy target.

An under-trial malaria vaccine was hailed as delivering "unprecedented efficacy levels" to achieve the WHO specified goal of 75 per cent efficacy and is now set to enter the next stage of trials, in collaboration with the Serum Institute of India.

Britain's GSK will shift production of the world's first effective malaria vaccine to Indian COVID-19 vaccine developer Bharat Biotech, as part of global efforts to battle the deadly fever, the drugmakers said on Wednesday.

Malaria is associated with high grade fever and is transmitted by the bite of an Anopheles mosquito.

Pakistan's government has launched a huge foreign-funded vaccination drive against typhoid that began on Nov 15.

World Malaria Day: In clinical trials, the vaccine was found to prevent about four in ten malaria cases, including three in ten cases of life-threatening severe malaria: reports.